Funding Details
- Awarder
- Inbox
- Date Award
- July 01, 2024
- Vertical
- Medical Devices
- Funding URL
- View Funding Page
Company Info
- Founding Year
- Not specified in the memo
- Traction
- The company is conducting a multi-center, 200-patient, randomized controlled trial in the U.S. to further validate the efficacy of its bioabsorbable perivascular wrap technology.
- Organizations Involved
- Norwest Venture Partners, Good Growth Capital, IAG Capital Partners, NIH
- Founders
- Tim Boire
- Company Description
- VenoStent develops a bioabsorbable perivascular wrap called SelfWrap, designed to accelerate the usability and increase the durability of fistula sites for chronic kidney disease (CKD) patients requiring hemodialysis. The company's technology uses the body’s own healing mechanisms to mimic the arterial environment in veins, addressing the challenges faced during AV creation for dialysis.
- Market
- Healthcare
- Location
-
Houston,
Texas,
US
- Coinvestors
- Norwest Venture Partners, Good Growth Capital, IAG Capital Partners
Links